chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Complained of muscle aches and fever requiring a visit to the ER.  This episode lasted less than 24 hours.  All tests and cultures were negative.  The physician told him that he felt the event was due to an allergic reaction to the flu vaccine.
My whole body hurt, I had a massive headache, wheezing coughing, I had a very hard time breathing. After a couple of days, my stomach was queasy, I became nauseous, I was not eating and some how I even had diarrhea. I went to my doctor because I could not breathe and was told to go to the emergency room because of the breathing. In the emergency room I was tested for COVID-19 that came back negative for COVID-19, but I was advised to test again at home the next day. I did an at home COVID-19, it came back positive, I tested again the day after that, it was again positive. I did retest the first Saturday in September and that test came back negative.
Little red spot on back, stomach; itching redspot; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Little red spot on back, stomach) and RASH PRURITIC (itching redspot) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included PRAVASTATIN, FINASTERIDE, LOSARTAN, SERTRALINE, TAMSULOSIN and VITAMINS NOS for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced RASH MACULAR (Little red spot on back, stomach) and RASH PRURITIC (itching redspot). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 20-Jan-2021 for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, RASH MACULAR (Little red spot on back, stomach) and RASH PRURITIC (itching redspot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Patient called and said his entire back is burning. He described the pain as "nerve damage." He said it might be shingles, but he feels it over his entire back. He has not seen a doctor yet.
Could hair loss be a side effect / alopecia; This case was reported by a consumer and described the occurrence of alopecia in a 64-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced alopecia. On an unknown date, the outcome of the alopecia was not recovered/not resolved.   It was unknown if the reporter considered the alopecia to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient had inquired if alopecia could be a side effect of Shingrix. The patient had already made an appointment with a dermatologist. The reporter consented to follow-up.
Presented to ED on 12/4/21 with first-time seizures (several episodes of 2-10 mins of generalized shaking with eyes open; unclear of duration between episodes or if pt returned to baseline between).  Found on CTH/CTV to have extensive CVST extending from superior sagittal, transverse, and sigmoid sinus on R.  Repeat CTH post-transfer with extension to R jugular bulb and R upper IJV.
I received my first dose on 9/10 at 4pm and on 9/12 around 10am I noticed I felt tightness in my chest and shortness of breath. My heart felt sore and was beating slightly harder than normal. It remained this way for 2 weeks. Things started feeling better after week 3.
Lymph node swelling; pain in left armpit; 3rd dose of vaccine; 3rd dose of vaccine; This is a spontaneous report from a contactable other hcp (nurse) (patient). A 39-year-old (non-pregnant) female patient received third bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0185) via an unspecified route of administration, administered in arm left on 28Aug2021 13:00 (at the age of 39-year-old) at dose 3, (booster) single for covid-19 immunisation. Medical history included known allergies: Hazelnut, pollen. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL); cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]); ibuprofen (IBUPROFEN); paracetamol (TYLENOL); montelukast sodium (SINGULAIR) all taken for an unspecified indication, start and stop date were not reported, patient received these medications within 2 weeks of vaccination. Patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EH9899) via an unspecified route of administration, administered in arm left on an unspecified date (at the age of 39-year-old) at dose 1, single for covid-19 immunisation and received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EL3249) via an unspecified route of administration, administered in arm left on 01Jul2021 (at the age of 39-year-old) at dose 2, single for covid-19 immunisation. On 28Aug2021 13:00 the patient experienced 3rd dose of vaccine, on 28Aug2021 21:00 the patient experienced lymph node swelling, pain in left armpit. Reported Event: Lymph node swelling and pain in left armpit after receiving 3rd dose of vaccine. Began. First noticed approximately 8hrs after receiving vaccine, still present 21hr after receiving vaccine. Patient did not received treatment for the adverse events. Outcome of the events lymph node swelling, pain in left armpit was not resolved and remaining other events were unknown.  Follow-Up (08Sep2021): Follow-up attempts are completed. No further information is expected.
got sick as a dog; Initial information received on 26-Dec-2022 regarding an unsolicited valid social media non-serious case from a consumer/non-hcp.  This case involves an unknown age and unknown gender patient who got sick as a dog after receiving influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided. It is unknown if the patient had any medical history, concomitant disease or risk factor.    On an unknown date, the patient received suspect influenza vaccine produced by unknown manufacturer at an unknown dose (lot number, expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination (Immunisation).  On an unknown date the patient got sick as a dog (illness) (unknown latency) following the administration of influenza vaccine.  It is unknown if there were lab data/results available.  Action taken: Not applicable.  Corrective treatment: Not reported.  Outcome: Unknown for the event got sick as a dog.
Information has been received from a nurse concerning a female patient who was vaccinated with GARDASIL. Subsequently the patient experienced severe liver function problems. The patient had sought unknown medical attention. At the time of report the patient's status was unknown. No further information is available.
My daughter was taken through innuendo and collusion by county social services and given to her father who she has never known. She was in foster care when she was reimmunized and did not need this because she was up to date on all her immunizations! Passed out shortly after immunization.
Person called and reported elevated blood sugars up to 183 since taking H1N1 vaccine. Also C/O being sleepy, anxious and pacing since taking the vaccine. 12/07/09 9:33 am called MD's office spoke with nurse denies giving pt. the vaccine. 12/08/09 Follow up with caller to confirm receiving vaccine at MD's office. Caller stated he was at a health fair an dthe MD arranged for him to go to his office (OB/GYN) to receive the vaccine. Stated he follow up with his own MD on yesterday 12/07/09. Metformin 500mg twice a day is being taken at own request to MD to prevent blood sugar from elevating. Caller stated blood sugar 148 at this time (3:41 pm).
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: Unknown. A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for Covid-19 immunisation. The patient's relevant medical history included: "Lupus" (unspecified if ongoing), notes: my wife has lupus. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 26Apr2022, outcome "unknown" and all described as "My wife is fully vaccinated; She had the Covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (26Apr2022) Positive; (27Apr2022) Negative; (28Apr2022) Negative; (29Apr2022) Negative; (30Apr2022) Negative; (01May2022) Negative. Therapeutic measures were taken as a result of Covid-19. Clinical course: It was reported that, first of all reporter want to say that It really was a miracle drug, reporter wife has lupus, Tuesday night last week she got sick, Wednesday morning she tested positive for Covid-19. Wednesday morning she was immediately given Paxlovid and discontinued her lupus Medication (further clarification unknown). By Sunday morning she had tested negative, she tested negative that she went to the urgent care tested negative at the urgent care, so from Wednesday onward she was positive so Sunday now was sudden she was negative. So the question was and reporter know there no where on the website. Patient wife was fully vaccinated (Pfizer Covid-19 vaccine), reporter also fully vaccinated. She had the Covid and she had the Paxlovid and she's now negative, was she still contagious that was she still have enough viral load to give Covid to anybody now that she negative 3 days in a row. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
lmpropely stored vaccine administered (37.94 F); This spontaneous report was received from a licensed practical nurse and refers to a 4-year-old female patient. No information regarding the patient's medical history, concurrent conditions and concomitant medications was provided.  On 20-AUG-2021, the patient was vaccinated in a public health clinic by the reporter (described also as a trained operator) with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # T002847, expiration date 23-JAN-2022 (dose number, dose, route of administration were not reported) for prophylaxis (product storage error). The administered vaccine was stored in clinical practice in a temperature of 37.94 degree Fahrenheit (F) for 100 hours. There was no previous temperature excursion. Digital data logger was involved. No prescription drug treatment for the experience was required. Temperature excursion detected vaccine was removed immediately after the reporting and no further vaccine was administered. The patient's parents were notified and the vaccination would be repeated with new vaccine stock.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2108USA006311:
This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and batch number: 1805031 expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 10:00 for prophylactic vaccination. No concomitant medications were reported. On 12-MAR-2021, the subject experienced urinary tract infection. On 12-MAR-2021, the subject experienced vaginal bleeding (bright red, only when urinating). On 12-MAR-2021, the subject experienced slight headache. On 12-MAR-2021 13:00, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from nausea, and had not recovered from vaginal bleeding (bright red, only when urinating), slight headache, and urinary tract infection. This report was non-serious.; Sender's Comments: V0 Medical assessment comment not required as per standard operating procedure as the case assessed as non-serious.
Patient came in on 03/10/2023 with father for 2nd dose pfizer vaccine. Noted due. Checked facility-approved "Covid Vaccine Schedule" Handout, rev. 10/13/2022. States in handout for pfizer 6mo-4y, 2nd dose primary. Did not in dotted note if monovalent or bivalent. Given Pzifer bivalent 0.2ml IM on rvl. tolerated well. no adverse reactions noted at this time. In the afternoon, nurse given updated "Covid Vaccine Schedule" handout, rev. 12/12/2022. Updated handout states on dotted note, "2nd dose primary monovalent." notified supervisor of event. chart cc'ed to md.
On 10/28/2000 the patient developed 2 or 3 vesicles on her chest and one 6cm vesicle on her buttock, and had a low grade fever. On 11/01/2000, the physician diagnosed the patient with varicella. The patient was treated with Neosporin and Infant Tylenol. The patient subsequently recovered. Additionally, the pharmacist also reported that her 12 month old fraternal twin had similar experiences following exposure to varicella virus vaccine live. Follow up information was received from a physician which indicated that there was no illness or pre-existing conditions at the time of vaccination. The reporting physician felt that there was no adverse experience for this patient. Additional follow up received from the physician indicated that the patient's mother called the office "ten days later with what sounded like an MMR rash, no Varivax. Additional information is not expected.
COVID-19 vaccine (Pfizer 5-11 years old; Lot # FL8094) administered to client at 3:00pm. While this 8 year old client is waiting for the end of the 15 minute observation period, at 3:10 pm, client stood up from her mother's lap and told her that she "couldn't see", and stumbled sideways, hitting her head on a wooden panel in the hallway. Mother stated she guided child slowly to lay her down on the floor, client stating "I don't want to die, I want to stay with you mom." Mother reported to the nurse that she saw her child hit the back side of her head on the wooden panel after she stumbled. Child was immediately assessed by the nurse, child is observed to be pale, however conscious and has her eyes open. Child was crying and seemed scared with this occurrence. Nurse checked the child's head for any injury or swelling, none noted at this time. Assisted child to the wheelchair and brought into the exam room, assisted the child to transfer to the exam table and laid her down for further observation. Vital signs checked at 3:16pm - Blood Pressure 135/90 mmHg; Pulse 110 bpm; Respirations 20, Oxygen Saturation via pulse oximeter 97%. Patient is alert and oriented to name and place, in no respiratory distress, denies any dizziness, and reported slight pain where she hit her head. Nurse re-assessed patient's head for any injury or swelling, none noted at this time. Ice pack placed on the client's back side of the head to provide comfort. Physician on site was notified immediately for further assessment. MD further evaluated the client, per MD no visual or palpable injuries noted on the patient's head or any other parts of her body noted at this time. Client is noted to be pale. Client reported that her last meal was breakfast time at school. MD recommended to observe client for 30 minutes more in the clinic. Mother reported that prior to today's vaccination, child was feeling anxious about COVID-19 disease and vaccination due to what is heard and seen in the news/media. Mother stated that this is the first time that the client had this kind of reaction after a vaccination, and feels that this occurrence is related to child's anxiety to current events. Vital signs re-checked at 3:28 pm Blood Pressure 125/69 mmHg; Pulse 116 bpm; Respirations 16; Oxygen Saturation via pulse oximeter 99%. After 30 minutes, client is observed to regain her normal color, talking more and is alert and oriented to name, time, and place, denies any headache, nausea, or dizziness. Nurse re-assessed client's head, no visual or palpable injuries noted at this time. On-site physician advised mother to follow-up with child's PMD as soon as possible, and to continue to observe the child for any headache, nausea, altered mental status, or sleepiness, if any of these occur to call the emergency number or take the child to the nearest Emergency Room as soon as possible. Client is ambulatory with a steady gait, discharged to home, accompanied by mother and sister.
Information has been received from a physician's office concerning a male child with no past medical history and no allergies who on 01/15/1999 was vaccinated with varicella vaccine. There was no concomitant medication. Subsequently, the pt "recently came down with a chicken pox." It was noted that the pt's father had shingles two weeks before the child broke out with chicken pox. Unspecified medical attention was sought. Additional info has been requested.
My son started getting hives on the arm and started spreading more after 24-48 hours on the arms and legs.  I gave him a Claritin a couple of hours ago and it has started to improve.
Myalgia, Fever, NauseaVomiting, CHILLS Narrative:
ok for awhile woke up from nap screaming x 3hrs, started jerking, stare & jerk on & off;no fever other than site quite about 9PM;
she started to have unspecififed itching; localised erythema; This spontaneous report has been received from a pharmacist, who was also the patient, a female patient of unknown age referring to herself. The patient's concurrent conditions, medical history, concomitant medications, previous drug reactions, or allergies were reported as none.     On 24-JAN-2022, the patient received the first dose of varicella virus vaccine live (oka/merck) (VARIVAX) on an unspecified arm, and on 21-FEB-2022, the patient received the second dose of varicella virus vaccine live (oka/merck) (VARIVAX) in her left arm; both vaccines with route of administration reported as injection, also the same lot number U025205 that has been verified to be a valid lot number with expiry date on 13-AUG-2023, indicated for varicella (strength, dose, and frequency were not provided).       On an unspecified date in February 2022 (also reported as a couple of days after the second dose), the patient started to have an unspecified itching that comes and goes predominantly on her arms, but can also be anywhere on her body (pruritus). The patient did not report a rash but did state that after she started itching and began to scratch, the are she scracted became red. Additionally, the patient reached out for medical attention with her health care professional (HCP) and was prescribed prednisone which she started on an unknown date in May 2022 (also reported as earlier this week).. Furthermore, on an unknown date, unspecified lab work was performed and came out with normal results.   The outcome of pruritus and erythema was reported as not recovered.  The causal relationship between varicella virus vaccine live (oka/merck) (VARIVAX) with pruritus and erythema was not reported.
LUMP UNDER LEFT ARM; This spontaneous report received from a patient concerned a female of unspecified age, race and ethnic origin. The patient's weight, height, and medical history were not reported. The patient previously received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported and batch number: 1809878, expiry: UNKNOWN) dose was not reported, 1 total, administered on 01-JUL-2021 to left arm for covid-19 prophylaxis. On 01-JUL-2021, after receiving the first dose of covid-19 vaccine ad26.cov2.s, the patient noticed that she had a lump under her left arm (Dose number in series 1). About 3 weeks after receiving the injection, she had a mammogram and everything was normal. The lump went away on its own shortly after the mammogram. The patient recovered from lump under left arm on JUL-2021. The patient additionally received booster dose of covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1822811, expiry: UNKNOWN) dose was not reported, 1 total, administered on NOV-2021 for covid-19 prophylaxis. No concomitant medications were reported. On an unspecified date in NOV-2021, following vaccination with covid-19 vaccine ad26.cov2.s, the patient experienced lump under left arm, a lump appeared and disappeared but after booster the recovery was faster (Dose number in Series 2). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lump under left arm on an unspecified date in 2021. This report was non-serious. This case, involving the same patient is linked to 20220728819 (Dose number in series 1).
Wife and husband went on Sunday for 1st Covid shot.. Following day wife was fine husband came home from work very sick, fever, sweating, chest pain, arm pain, facial pain, hands and thumbs in pain. Can't sleep been happening every day, comes and goes with pain medication (ibuprofen) pain is unbearable,  going on day 6.
Itching, redness, soreness at injection site 4-5 inch diameter red area.
Hasn't had her second dose and is past the six week mark; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Hasn't had her second dose and is past the six week mark) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Hasn't had her second dose and is past the six week mark). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Hasn't had her second dose and is past the six week mark) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Relevant concomitant medications were not provided. Treatment information was not provided.   Reporter did not allow further contact
Large red, raised band at injection site about 5 inches in length that goes 3/4 way around arm. Painful, some itching. MD advised pt to take ibuprofen, BENADRYL and apply cold compress. MD advised to go to ER if gets any worse.
pt recv vax 3JUL97 & 4JUL97 pt devel a sl fever & a rash on chest;6JUL97 pt rash resolved;
Patient dropped phone complaining of L arm pain and not being able to move it. On exam, pt was able to move it, but did have decreased (but improving) ROM.
Flublok was administered to him instead of the Fluarix as he is 17 years old.  He received the vaccine and did not have any reactions.  His mother was notified the next day after it was found out and she states that she would have never known that he received the wrong vaccine because he has not had any symptoms or side effects.
Patient was given MMR vaccine with expired diluent. The MMR vaccine itself was not expired, but the diluent was.
Brachial Neuritis left arm with pain that woke her from sleep the night after receiving the vaccine. Gradually improved over the next week. As of 21 Dec 2017, her symptoms have decreased with the exception of persistent increased sensitivity to touch.